Compounds > idarubicin
Page last updated: 2024-08-23

idarubicin and Disease Models, Animal

idarubicin has been researched along with Disease Models, Animal in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ1
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV1
Freireich, EJ; Jendiroba, D; Keyhani, A; Liu, B; Pagliaro, L; Pearlman, M; Travis, E1
Cattan, AR; Maung, ZT1
Animati, F; Arcamone, F; Bigioni, M; Capranico, G; Caserini, C; Cipollone, A; De Cesare, M; Ettorre, A; Guano, F; Manzini, S; Monteagudo, E; Pratesi, G; Salvatore, C; Supino, R; Zunino, F1

Other Studies

5 other study(ies) available for idarubicin and Disease Models, Animal

ArticleYear
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
    Science translational medicine, 2019, 07-10, Volume: 11, Issue:500

    Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries

2019
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection

2020
Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity.
    Cancer chemotherapy and pharmacology, 2003, Volume: 52, Issue:6

    Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Disease Models, Animal; Doxorubicin; Idarubicin; Injections, Intraperitoneal; Jejunal Diseases; Jejunum; Male; Mice; Mice, Inbred C3H; Protective Agents; Razoxane

2003
A comparison of a CB17 scid mouse model and the tetrazolium-dye assay using human haematological tumour cell lines.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Animals; Antineoplastic Agents; Burkitt Lymphoma; Coloring Agents; Daunorubicin; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Idarubicin; Leukemia, Experimental; Male; Mice; Mice, SCID; Multiple Myeloma; Tetrazolium Salts; Toxicity Tests; Tumor Cells, Cultured

1996
Configurational requirements of the sugar moiety for the pharmacological activity of anthracycline disaccharides.
    Biochemical pharmacology, 1999, May-15, Volume: 57, Issue:10

    Topics: Animals; Anthracyclines; Antineoplastic Agents; Disaccharides; Disease Models, Animal; DNA; Humans; Idarubicin; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mice; Mice, Nude; Molecular Conformation; Recombinant Proteins; Structure-Activity Relationship; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

1999